SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
New Mouse Model Mimics Hyperglycemia, Aids In Diabetes Research At UT Southwestern Medical Center
June 6, 2008
 · 
1 min read
Lone Star Bio
Cartilage Regeneration ’20,000 Leagues Under The Sea'; Rice University Engineers Use High Pressure To Stimulate Growth Of New Cartilage
June 5, 2008
 · 
1 min read
Drug Development
New West Nile And Japanese Encephalitis ‘Pseudoinfectious’ Vaccines Produced At University of Texas
June 2, 2008
 · 
1 min read
Lone Star Bio
Nanoparticles Assemble By Millions To Encase Oil Drops, Rice University Study
May 30, 2008
 · 
1 min read
Lone Star Bio
National Instruments Corporation Advances Medical Device Design with Technology and Training
May 30, 2008
 · 
1 min read
Drug Development
Fireflies’ Glow Helps UT Southwestern Medical Center Researchers Track Cancer Drug’s Effectiveness
May 29, 2008
 · 
1 min read
Lone Star Bio
CT May Better Predict Those At Higher Risk For Heart Disease, University of Texas Southwestern Medical Center Study
May 28, 2008
 · 
1 min read
Biotech Bay
Taking the Gloves Off
May 27, 2008
 · 
2 min read
Lone Star Bio
Oocyte-Specific Gene Mutations Cause Premature Ovarian Failure, Baylor College of Medicine And Shandong University Study Finds
May 23, 2008
 · 
1 min read
Lone Star Bio
Monitors Urged By American Heart Association For All With High Blood Pressure
May 23, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Colossal Foundation and University of Tasmania Partner to Combat Devil Facial Tumour Disease with Vaccines and Gene Editing
July 1, 2026
 · 
11 min read
Press Releases
Vizient Forecasts 20% Growth in Outpatient Care, 7% in Inpatient Care
June 30, 2026
 · 
3 min read
Press Releases
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration
June 30, 2026
 · 
4 min read
Press Releases
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
June 30, 2026
 · 
1 min read
Press Releases
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control
June 30, 2026
 · 
9 min read
Press Releases
Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding
June 30, 2026
 · 
10 min read
Press Releases
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 30, 2026
 · 
5 min read
Press Releases
Texas Biomed and Flyttr partner to advance next-generation solutions for the invasive New World screwworm
June 29, 2026
 · 
3 min read
Press Releases
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
June 29, 2026
 · 
6 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Load More